WO1999040215A1 - Mortierella - Google Patents
Mortierella Download PDFInfo
- Publication number
- WO1999040215A1 WO1999040215A1 PCT/GB1999/000211 GB9900211W WO9940215A1 WO 1999040215 A1 WO1999040215 A1 WO 1999040215A1 GB 9900211 W GB9900211 W GB 9900211W WO 9940215 A1 WO9940215 A1 WO 9940215A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mortierella
- culture
- organism
- accordance
- culturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Definitions
- MORT1ERELLA relates to Mortierella.
- Mortierella a genus of filamentous fungus, is of industrial interest because at least some members produce lipids which contain residues of poly-unsaturated fatty acids, especially arachidonic acid and of other poly-unsaturated fatty acids metabolisable by human beings thereto, for example gamma linolenic acid.
- Such lipids and/or such acids derived therefrom are considered to be beneficial to human health when used as nutritional supplements. Addition of such lipids and/or acids to infant formula (artificial milk for human babies) has been proposed in order to simulate human mothers' milk more closely.
- the acids, lipids or the organisms themselves may be eaten, their poly- unsaturated fatty acids then becoming available by normal processes of digestion.
- Mortierella the desired organisms
- Mortierella filaments generally tend to be highly tangled, such that it is in general not possible to distinguish one individual from another in order to quantify morphological characteristics.
- non-tangled ends protrude from tangled masses, and examination of these indicates that the desired organisms are more highly branched than corresponding known organisms.
- the desired organisms have a more compact morphology, corresponding to the greater extent of branching, than known varieties. It is not known why or how the desired organisms adhere less readily to solid surfaces.
- a number of strains may be cultured and under comparable conditions in liquid culture and plate culture.
- the nutrient medium for the plates may differ from that used in liquid culture.
- the area covered after a period of such plate culture is substantially less in the case of the desired organisms than in the case of other organisms of similar liquid culture growth rate.
- the areas covered by a desired organism is less than half, and preferably less than one quarter of that covered by a known strain of Mortierella of similar growth rate in liquid culture.
- the invention comprises novel strains of Mortierella having a morphology index M as above defined of at most 4 x 10 3 ⁇ m and preferably at most 3.5 x 10 3 ⁇ m.
- the suitable strains of Mortierella may be for example: M.alpina, M.bainieri, M.elongata, M.exigua, M.hygrophila, M.globalpina, M.minutissima, M.verticillata,
- M.polycepuala and M.zyzchae may produce eicosapentaenoic acid, gamma linolenic acid (GLA) or preferably arachidonic acid and/or their derivatives, especially lipids containing their residues, depending on process conditions.
- GLA gamma linolenic acid
- arachidonic acid especially lipids containing their residues, depending on process conditions.
- the invention further provides methods of selecting the novel Mortierella strains.
- One such method comprises culturing strains on agar plates under similar conditions and selecting those which have a small colony area. Strains which show little growth observed as a low density in the colony area should be disregarded. Strains so selected are the most likely to have a desirable morphology index. Suitable strains may be produced by prolonged culturing of Mortierella strains under conditions of nutrient limitation (especially nitrogen limitation), followed by selection of individuals of appropriate value of colony area and/or morphology. Such individuals may then be cultured suitably under conditions of nutrient limitation, and selection may be repeated if required.
- nutrient limitation especially nitrogen limitation
- the invention comprises a process of culturing Mortierella in a fermenter which comprises selecting an organism of compact morphology from the culture preferably after continuing culture until substantial adherence of Mortierella to surfaces of the fermenter has occurred and carrying out a subsequent fermentation of the said more compact organism. The procedure may be repeated as often as desired until an organism which has low adhesion to surfaces is obtained.
- low adhesion to surfaces is meant that the rate of removal of the organisms from surfaces under normal conditions of turbulence encountered in fermentation is sufficient to prevent a build-up of deposits on such surfaces.
- the invention also provides a process for producing a lipid which comprises a step of culturing Mortierella as above described.
- a medium is initially inoculated with organisms which are grown to a desired content of the organisms and then preferably further cultivated after exhaustion of one or more nutrients, and the biomass then harvested.
- the supply of one or more nutrients may be replenished during culture ("fed batch”).
- feed batch fresh nutrient(s) are added and product removed without discontinuing culture.
- Such addition and removal may be continuous or intermittent.
- the new variety of Mortierella is advantageous for batch or fed batch operation, but is particularly suitable for continuous culture. In each mode the new Mortierella forms a more homogeneous mixture and thus affords better mixing, and thus in general faster and/or greater biomass formation.
- Continuous culture may be carried out in known manner, for example in an air lift fermenter (which has no moving parts but in which conduits may become clogged with known varieties) or in stirred vessels.
- Organisms according to the invention may typically be grown at a pH of 4 to 10 and preferably 6 to 8.
- the pH is preferably controlled to rise from an initial value of 5 to 6 to a final value of 6.5 to 7.5.
- the temperature may be 5-40 and preferably 20-30,°C.
- the organisms may be cultured on a solid medium but preferably a liquid medium is used.
- the carbon source in the liquid may comprise solubles, for example glucose, fructose, sucrose, maltose or soluble starch, or low-solubility carbohydrates, fatty acids or lipids and/or (in the case of organisms which metabolise hydrocarbons for growth) hydrocarbons.
- the nitrogen source may be complex, for example proteins, peptides and/or amino acids, for example yeast extract, meat extract, corn steep liquor; or simple for example nitrate and/or ammonium ions, ammonium ions being supplied for example as sulphate or gaseous ammonia, or it may be a mixture of complex and simple sources.
- the source of phosphate is suitably inorganic. Trace elements and vitamins may be included.
- the concentration (w/w on total medium) of carbon source is preferably at least 0.1%, possibly 30% or more, but preferably in the range 1-15%, for example 2-10%.
- the concentration (w/w on total medium) of nitrogen source is for example 0.01 to 1 , especially 0.1 to 0.4%, calculated as equivalent N.
- a plurality of carbon sources may be employed.
- a phase of cultivation after exhaustion of a nutrient other than the carbon materials, especially nitrogen or phosphate, is preferably operated.
- Culturing is aerobic, suitably in the presence of dissolved oxygen supplied as air, possibly enriched.
- the culture is suitably agitated for example by stirring or by flow of gas.
- an airlift fermenter in which circulation of liquid is maintained by gas, for example oxygen or air, injection
- Cultured cells are suitably subjected to extraction for example with an organic solvent, for example, hexane, an ester or an alcohol possibly in combination or succession. If desired, extraction may take place with a halogenated hydrocarbon, for example chloroform, but it is preferred to use hydrocarbons or alcohols or esters as extractants in order to avoid environmental problems.
- Mortierella Alpina ATCC 32222 was grown in continuous culture at pH 6.8, 26°C under aerobic conditions where the dissolved oxygen tension (DOT) was maintained at a level above 20% of air saturation.
- the culture was grown on SD4 medium, (see table below) with excess glucose added as primary carbon source such that the glucose was maintained at a standing concentration of 5 to 20 g/l in the culture throughout the fermentation and ammonium sulphate was the limiting substrate.
- the medium was added at a rate equivalent to a dilution rate of 0.05 h "1 .
- Each day samples of culture were removed from the fermenter, grown on S2GYE agar plates (see Appendix 2) and the resulting colonies carefully examined for colonial variants.
- colonial variants were observed. It was noted that these colonial variant colonies covered smaller areas than the original parent organism. Moreover, the colonial variants were more highly branched.
- colonial variant strains now constituted 88% of the population present.
- a pure culture of a new colonial variant was grown on S2GYE plates at 28°C.
- a spore suspension was prepared by aseptically transferring spores on the hyphae into sterile saline solution. A 10 ⁇ l drop of the solution of spores was then transferred to the centre of agar plates containing the desired medium.
- the plates were then incubated at 28°C and the rate of colony expansion measured each day, by measuring the diameter of the colony on each plate at 2 perpendicular positions. This was carried out on 4 different types of medium
- the radial growth rate was calculated each day and an average rate determined over the growth period (see Appendix 3). From the data it can be seen that the radial expansion rate of the new strain is significantly lower than that of the original strain.
- the new organism was cultivated in liquid medium (see appendix 4) at 26°C under aerobic conditions. A batch fermentation was used, with a starting pH of 6.8, in which the culture pH was prevented from falling by the addition of sterile 2 molar NaOH. No control was exerted to prevent a rise in pH.
- the maximum growth rate of the organism was determined by measurement of the CO 2 evolution rate (CER). Similarly the original organism was cultivated under the same conditions and its maximum growth rate determined by the same means.
- S2GYE was seed 2 medium with glucose added to a final concentration of 45 g/l.
- Yeast extract (Oxoid L21) added to a final concentration of 5 g/l and Agar (Oxoid
- Potato Dextrose Agar was obtained from Oxoid (CM 139). It is made up as follows:
- the new strain was depos _ .i_t.e...d__ o - .n_ .8-111 1 January 1998 under deposit number IMI 378077 with Commonwealth Agricultural Bureau, International Mycological Institute, Ferry Lane, Kew, Surrey TW9 3AF, United Kingdom, (now of UK Centre (Egham), Bakeham Lane, Egham, Surrey, TW20 9TY)
- Microorganism Mortierella alpina IMI CC Number: 378077
- Microorganism Mortierella alpina IMI CC Number: 378077
- IIBC International tf__8g_WSP8 ⁇ __WCg ⁇ c l Control
- HE 1 Entomology
- IIi International Mycological Institute
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU21772/99A AU2177299A (en) | 1998-02-07 | 1999-01-21 | Mortierella |
BR9907701-9A BR9907701A (en) | 1998-02-07 | 1999-01-21 | Process for growing mortierella in a fermenter, variety of mortierella, processes for selecting and producing a variety of mortierella and for producing lipids or foods comprising lipids, and, mortierella |
EP99901772A EP1053344A1 (en) | 1998-02-07 | 1999-01-21 | Mortierella |
CA002320407A CA2320407A1 (en) | 1998-02-07 | 1999-01-21 | Mortierella |
KR1020007008616A KR20010040732A (en) | 1998-02-07 | 1999-01-21 | Mortierella |
JP2000530626A JP2002502612A (en) | 1998-02-07 | 1999-01-21 | Mortierella |
NO20003981A NO20003981L (en) | 1998-02-07 | 2000-08-07 | Mortierella |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9802561.2 | 1998-02-07 | ||
GBGB9802561.2A GB9802561D0 (en) | 1998-02-07 | 1998-02-07 | Mortierella |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999040215A1 true WO1999040215A1 (en) | 1999-08-12 |
Family
ID=10826579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/000211 WO1999040215A1 (en) | 1998-02-07 | 1999-01-21 | Mortierella |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1053344A1 (en) |
JP (1) | JP2002502612A (en) |
KR (1) | KR20010040732A (en) |
CN (1) | CN1296527A (en) |
AU (1) | AU2177299A (en) |
BR (1) | BR9907701A (en) |
CA (1) | CA2320407A1 (en) |
GB (1) | GB9802561D0 (en) |
ID (1) | ID26203A (en) |
NO (1) | NO20003981L (en) |
WO (1) | WO1999040215A1 (en) |
ZA (1) | ZA99738B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02142486A (en) * | 1988-11-25 | 1990-05-31 | Lion Corp | Production of unsaturated fatty acid-containing lipid |
WO1996021037A1 (en) * | 1995-01-03 | 1996-07-11 | Martek Biosciences Corporation | Arachidonic acid and methods for the production and use thereof |
WO1998029558A1 (en) * | 1996-12-27 | 1998-07-09 | Suntory Limited | Media for culturing microorganisms and process for producing unsaturated fatty acids or lipids containing the same |
-
1998
- 1998-02-07 GB GBGB9802561.2A patent/GB9802561D0/en not_active Ceased
-
1999
- 1999-01-21 CN CN99804853A patent/CN1296527A/en active Pending
- 1999-01-21 ID IDW20001667A patent/ID26203A/en unknown
- 1999-01-21 BR BR9907701-9A patent/BR9907701A/en not_active Application Discontinuation
- 1999-01-21 AU AU21772/99A patent/AU2177299A/en not_active Abandoned
- 1999-01-21 KR KR1020007008616A patent/KR20010040732A/en not_active Application Discontinuation
- 1999-01-21 EP EP99901772A patent/EP1053344A1/en not_active Withdrawn
- 1999-01-21 JP JP2000530626A patent/JP2002502612A/en active Pending
- 1999-01-21 CA CA002320407A patent/CA2320407A1/en not_active Abandoned
- 1999-01-21 WO PCT/GB1999/000211 patent/WO1999040215A1/en not_active Application Discontinuation
- 1999-01-29 ZA ZA9900738A patent/ZA99738B/en unknown
-
2000
- 2000-08-07 NO NO20003981A patent/NO20003981L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02142486A (en) * | 1988-11-25 | 1990-05-31 | Lion Corp | Production of unsaturated fatty acid-containing lipid |
WO1996021037A1 (en) * | 1995-01-03 | 1996-07-11 | Martek Biosciences Corporation | Arachidonic acid and methods for the production and use thereof |
WO1998029558A1 (en) * | 1996-12-27 | 1998-07-09 | Suntory Limited | Media for culturing microorganisms and process for producing unsaturated fatty acids or lipids containing the same |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Section Ch Week 9028, Derwent World Patents Index; Class D16, AN 90-213068, XP002102400 * |
Also Published As
Publication number | Publication date |
---|---|
EP1053344A1 (en) | 2000-11-22 |
KR20010040732A (en) | 2001-05-15 |
NO20003981D0 (en) | 2000-08-07 |
JP2002502612A (en) | 2002-01-29 |
ZA99738B (en) | 1999-08-10 |
BR9907701A (en) | 2001-09-04 |
CN1296527A (en) | 2001-05-23 |
CA2320407A1 (en) | 1999-08-12 |
ID26203A (en) | 2000-12-07 |
NO20003981L (en) | 2000-09-12 |
AU2177299A (en) | 1999-08-23 |
GB9802561D0 (en) | 1998-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900007936B1 (en) | Novel microorganism aureobasidium spp. | |
ES2762618T3 (en) | Microorganisms that produce docosahexaenoic acid and their use | |
CN107164238B (en) | Schizochytrium limacinum strain and mutagenesis method and application thereof | |
JPH03232497A (en) | Production of l-glutamine by fermentation | |
CN103882072B (en) | A kind of method utilizing schizochytrium limacinum to produce docosahexenoic acid | |
CN101215529A (en) | Alpha-ketoglutaric acid high yield bacterium, screening method thereof and production of alpha-ketoglutaric acid from the same by fermentation method | |
JP2764572B2 (en) | Novel microorganism having docosahexaenoic acid-producing ability and method for producing docosahexaenoic acid using the same | |
CN101113410B (en) | Mortierella alpina and application thereof | |
CN110713956B (en) | Lysine bacillus S12 and application thereof | |
JP4132253B2 (en) | Ammonia-resistant L (+)-lactic acid-producing bacterium and L (+)-lactic acid production method | |
AU654488B2 (en) | Proteinaceous compositions from filamentous microorganisms, the branching of which is regulated by calcium ion concentration | |
WO1999040215A1 (en) | Mortierella | |
CN1141377C (en) | High-content mycose saccharomycetes and its preparing process | |
CA1056749A (en) | Method of producing long-chain alpha-hydroxyalkanoic acids | |
RU2096461C1 (en) | Yeast strain yarrowia lipolytica - producer of citric acid and method of citric acid production | |
JPS6314697A (en) | Production of eicosapentaenoic acid | |
MXPA00007710A (en) | Mortierella | |
DK171744B1 (en) | Process for the preparation of pyruvic acid | |
CN103484385B (en) | Mortierella alpina mutant strain capable of producing high-yield arachidonic acid, and fermentation method and application thereof | |
KR100208968B1 (en) | A novel saccharomyces cerevisiae ns9 which is used for producing yeast extract contained high density of nucleic acid | |
KR0177478B1 (en) | Candida genus strain having erythritol producing ability and preparation method of erythritol using the same | |
RU2747583C1 (en) | Method for synthesis of (2r, 3s)-isocitric acid from sunflower seed oil using yarrowia lipolytica yeast | |
JP2018038275A (en) | Microorganisms belonging to labyrinthula aurantiochytrium genus and lipid production method using said microorganisms | |
KR100671081B1 (en) | Microorganism producing inosine and process of preparing 5'-inosinic acid using same | |
KR0141404B1 (en) | Novel saccharomyces cerevisiae ns53 which produces high density nucleic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99804853.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2320407 Country of ref document: CA Ref document number: 2320407 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020007008616 Country of ref document: KR Ref document number: 21772/99 Country of ref document: AU Ref document number: IN/PCT/2000/00127/DE Country of ref document: IN Ref document number: PA/a/2000/007710 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999901772 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200000778 Country of ref document: VN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09601728 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999901772 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007008616 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999901772 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020007008616 Country of ref document: KR |